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ACC/AHA Practice Guidelines
The ACC/AHA classifications, I, II, and III are used to
summarize indications as follows:
Class I: Conditions for which there is evidence and/or
general agreement that a given procedure or
treatment is useful and effective.
Class II: Conditions for which there is conflicting evi-
dence and/or a divergence of opinion about the
usefulness/efficacy of a procedure or treatment.
IIa: Weight of evidence/opinion is in favor of
usefulness/efficacy.
IIb: Usefulness/efficacy is less well established
by evidence/opinion.
Class III: Conditions for which there is evidence and/or
general agreement that the procedure/treatment
is not useful/effective and in some cases may be
harmful.
In the original guideline, the committee did not rank the
available scientific evidence in an A, B, or C fashion. The
level of evidence is provided for the new recommendations
appearing in the update. The weight of the evidence was
ranked highest (A) if the data were derived from multiple
randomized clinical trials that involved large numbers of
patients and intermediate (B) if the data were derived from a
limited number of randomized trials that involved small
numbers of patients or from careful analyses of nonrandom-
ized studies or observational registries. A lower rank (C) was
given when expert consensus was the primary basis for the
recommendation.
The ACC/AHA Task Force on Practice Guidelines wel-
comes feedback on this update process and the format of this
article. Please direct your comments to the Task Force c/o
Dawn Phoubandith, American College of Cardiology or via
e-mail (dphouban@acc.org).
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Modification I
The text in the 1997 guidelines that appeared under the major
heading “Diagnosis” and the subheading “Influence of
Other Factors on Test Performance” has been extensively
reorganized. This began on page 272 (second column) of the
original guidelines. New material regarding ST–heart rate
and adjustment changes during and after exercise is repro-
duced below. New material on atrial repolarization and right
chest leads appears in the full-text guidelines on the Internet.
ST–Heart Rate Adjustment
Several methods of heart rate adjustment have been proposed
to increase the diagnostic accuracy of the exercise ECG. The
maximal slope of the ST segment relative to heart rate is
derived either manually (1) or by computer (2). A second
technique, termed the ST/HR index, divides the difference
between ST depression at peak exercise by the exercise-
induced increase in heart rate (3,4). ST/HR adjustment has
been the subject of several reviews since the last publication
of these guidelines (5,6). The major studies that used this
approach for diagnostic testing include Morise’s report (7) of
1358 individuals undergoing exercise testing (only 152 with
catheterization data) and the report by Okin et al (8) consid-
ering heart rate reserve (238 controls and 337 patients with
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coronary disease). Viik et al considered the maximum value
of the ST-segment depression/heart rate (ST/HR) hysteresis
over a different number of leads for the detection of coronary
artery disease (CAD) (9). The study population consisted of
127 patients with coronary disease and 220 patients with a
low likelihood of the disease referred for an exercise test.
Neither the study by Okin et al or that by Viik et al considered
consecutive patients with chest pain, and both had limited
challenge. Because healthy patients have relatively high heart
rates and sick patients have low heart rates, which leads to a
lower ST/HR index in normals and a higher index in sicker
patients, the enrollment of relatively healthy patients in these
studies presents a limited challenge to the ST/HR index.
Likewise, the Morise study (7) had a small number of patients
who underwent angiography. The only study with neither of
these limitations was QUEXTA (10). This large multicenter
study followed a protocol to reduce workup bias and was
analyzed by independent statisticians. The ST/HR slope or
index was not found to be more accurate than simple
measurement of the ST segment. Although some studies in
asymptomatic (and therefore very low likelihood) individuals
have demonstrated additional prognostic value with ST/HR
adjustment, these data are not directly applicable to the issue
of diagnosis in symptomatic patients (11,12). Nevertheless,
one could take the perspective that the ST/HR approach in
symptomatic patients has at least equivalent accuracy to the
standard approach. Although not yet validated, there are
situations in which the ST/HR approach could prove useful,
such as in rendering a judgment concerning certain borderline
or equivocal ST responses, eg, ST-segment depression asso-
ciated with a very high exercise heart rate.
In asymptomatic patients, in MRFIT, significant concen-
tration of cardiac risk was associated with an abnormal
ST/HR index but not with abnormal standard exercise test
criteria as judged by computer interpretation (12). Compared
with patients in the usual care group, cardiac events were
reduced in the risk factor modification group when the
exercise test was positive according to the ST/HR index (13).
Modification II
These revised recommendations (see top of page) incorporate
new recommendations for risk stratification in patients with
unstable angina. The table of recommendations originally
appeared at the beginning of the heading on “Risk Assess-
ment” on page 274 (first column).
Modification II
1997 Exercise Testing Guideline Recommendation 2002 Exercise Testing Guideline Recommendation
Class I Class I
1. Patients undergoing initial evaluation with suspected or
known CAD. Specific exceptions are noted below in Class IIb.
1. Patients undergoing initial evaluation with suspected or known CAD,
including those with complete right bundle-branch block or less than 1 mm of
resting ST depression. Specific exceptions are noted below in Class IIb.
2. Patients with suspected or known CAD previously evaluated
with significant change in clinical status.
2. Patients with suspected or known CAD, previously evaluated, now
presenting with significant change in clinical status.
3. Low-risk unstable angina patients (see Table 17) 8 to 12 hours after
presentation who have been free of active ischemic or heart failure symptoms.
(Level of Evidence: B)
4. Intermediate-risk unstable angina patients (see Table 17) 2 to 3 days
after presentation who have been free of active ischemic or heart failure
symptoms. (Level of Evidence: B)
Class IIa Class IIa
1. Intermediate-risk unstable angina patients (see Table 17) who have initial
cardiac markers that are normal, a repeat ECG without significant change, and
cardiac markers 6 to 12 hours after the onset of symptoms that are normal
and no other evidence of ischemia during observation. (Level of Evidence: B)
Class IIb Class IIb
1. Patients with the following ECG abnormalities 1. Patients with the following resting ECG abnormalities
● Pre-excitation (Wolff-Parkinson-White) syndrome ● Pre-excitation (Wolff-Parkinson-White) syndrome
● Electronically paced ventricular rhythm ● Electronically paced ventricular rhythm
● Greater than 1 mm of resting ST depression ● 1 mm or more of resting ST depression
● Complete left bundle-branch block ● Complete left bundle-branch block or any interventricular conduction
defect with a QRS duration greater than 120 ms
2. Patients with a stable clinical course who undergo periodic
monitoring to guide treatment.
2. Patients with a stable clinical course who undergo periodic monitoring to
guide treatment.
Class III Class III
1. Patients with severe comorbidity likely to limit life expectancy
and/or candidacy for revascularization.
1. Patients with severe comorbidity likely to limit life expectancy and/or
candidacy for revascularization.
2. High-risk unstable angina patients (see Table 17). (Level of Evidence: C)
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Modification III
This revised text incorporates new published evidence on
elderly patients, heart-rate responses during and after exer-
cise, and systolic blood pressure responses during and after
exercise. It replaces material in the original text that ap-
peared under the major heading “Risk Stratification” and the
subheading “Nonacute Coronary Artery Disease” beginning
on page 278 (second column).
The value of exercise treadmill testing for prognostic
assessment in elderly subjects has been described in the
Olmstead County, Minnesota, cohort followed by the Mayo
Clinic (14). As expected, the elderly patients (aged greater
than or equal to 65 years) had more comorbidity and achieved
a lower workload than their younger counterparts. They also
had a significantly worse unadjusted survival. Workload
expressed as metabolic equivalents (METs) was the only
treadmill variable associated with all-cause mortality in both
groups (adjusting for clinical prognostic variables), whereas
both workload and exercise angina were associated with
cardiac events (death plus myocardial infarction) in both
groups. A positive ST response was not prognostic in the
older patients when tested as a binary variable. Quantitative
ST-segment deviation with exercise was apparently not avail-
able in this cohort, and the Duke Treadmill Score was not
computed in this study.
Morrow and colleagues (15) developed a prognostic score
using data from 2546 patients from Long Beach Veterans
Administration Hospital. This score includes 2 variables in
common with the Duke treadmill score (exercise duration or the
MET equivalent and millimeters of ST changes) and 2 different
variables (drop in exercise systolic blood pressure below resting
value and history of congestive heart failure [CHF] or use of
digoxin [Dig]). The score is calculated as follows:
5  (CHF/Dig [yes1; no0])  exercise-induced ST
depression in millimeters change in systolic blood pressure
score  METs,
where systolic blood pressure0 for an increase greater
than 40 mm Hg, 1 for an increase of 31 to 40 mm Hg, 2 for
an increase of 21 to 30 mm Hg, 4 for an increase of 0 to
11 mm Hg, and 5 for a reduction below standing systolic
preexercise blood pressure. With this score, 77% of the Long
Beach Veterans Administration Hospital population were at
low risk (with less than 2% average annual mortality), 18%
were at moderate risk (average annual mortality, 7%), and 6%
were at high risk (average annual mortality, 15%).
Several studies have highlighted the prognostic importance
of other parameters from the exercise test. Chronotropic
incompetence, defined as either failure to achieve 80% to
85% of the age-predicted maximum exercise heart rate or a
low chronotropic index (heart rate adjusted to MET level),
was associated with an 84% increase in the risk of all-cause
mortality over a 2-year follow-up in 1877 men and 1076
women who were referred to the Cleveland Clinic for
symptom-limited thallium treadmill testing (16,17). The
Cleveland Clinic investigators have also demonstrated the
prognostic importance of an abnormal heart rate recovery
pattern after exercise testing. Defined as a change from peak
exercise heart rate to heart rate measured 2 minutes later of
less than or equal to 12 beats per minute, an abnormal heart
rate recovery was strongly predictive of all-cause mortality at
6 years in 2428 patients referred for thallium exercise testing
(18). Similar trends have been suggested for a delayed
systolic blood pressure response after exercise, defined as a
value greater than 1 for systolic blood pressure at 3 minutes
of recovery divided by systolic blood pressure at 1 minute of
recovery. This finding was associated with severe CAD in a
study of 493 patients at the Cleveland Clinic who had both
symptom-limited exercise testing and coronary angiography
(within 90 days) (19). In a study of 9454 consecutive patients,
most of whom were asymptomatic, the Cleveland Clinic
investigators reported that abnormal heart rate recovery and
the Duke treadmill score were independent predictors of
mortality (20). Further work is needed to define the role of
chronotropic incompetence, abnormal heart rate recovery,
and delayed blood pressure response in the risk stratification
of symptomatic patients relative to other well-validated tread-
mill test parameters.
In patients who are classified as low risk on the basis of
clinical and exercise testing information, there is no compel-
ling evidence that an imaging modality adds significant new
prognostic information to a standard exercise test. In this
regard, a distinction should be made between studies that
show a statistical advantage of imaging studies over exercise
ECG alone and studies that demonstrate that the imaging data
would change practice (eg, by shifting patients from
moderate- to low- or high-risk categories). Because of its
simplicity, lower cost, and widespread familiarity in its
performance and interpretation, the standard treadmill ECG is
the most reasonable exercise test to select in men with a
normal resting ECG who are able to exercise. In patients with
an intermediate-risk treadmill score, myocardial perfusion
imaging appears to be of value for further risk stratification
(21). Patients with an intermediate-risk treadmill score and
normal or near-normal exercise myocardial perfusion images
and normal cardiac size are at low risk for future cardiac
death and can be managed medically (22).
Modification IV
This revised text, revised Table 17, and new Table 17a
incorporate new published evidence regarding patients with
unstable angina and the use of treadmill testing in chest pain
centers. They replace text and Table 17 that originally
appeared under the major heading “Risk Stratification” and
the subheading “Unstable Angina,” beginning on page 280
(first column).
Patients With Acute Coronary Syndrome
Acute coronary syndrome (unstable angina or acute myocar-
dial infarction) represents an acute phase in the life cycle of
the patient with chronic coronary disease. It may be a
presenting feature or may interrupt a quiescent phase of
clinically manifested disease. The natural history of ACS
involves progression to either death or myocardial infarction
on the one hand or return to the chronic stable phase of CAD
on the other. These events typically play out over a period of
4 to 6 weeks. Thus, the role and timing of exercise testing in
ACS relates to this acute and convalescent period.
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The ACC/AHA 2002 Guideline Update for the Manage-
ment of Patients With Unstable Angina and Non–ST-
Segment Elevation Myocardial Infarction has been published
(23). A clinical risk stratification algorithm useful for select-
ing the initial management strategy is seen in the revised
Table 17. Patients are separated into low-, intermediate-, or
high-risk groups based on history, physical examination,
initial 12-lead ECG, and cardiac markers. (Note that this table
is meant to be illustrative rather than comprehensive or
definitive.) Low-risk patients, who include patients with
new-onset or progressive angina with symptoms provoked by
walking 1 block or 1 flight of stairs, in this scheme can
typically be treated on an outpatient basis. Most intermediate-
risk patients can be cared for in a monitored hospital bed,
whereas high-risk patients are typically admitted to an inten-
sive care unit.
Exercise or pharmacological stress testing should generally
be an integral part of the evaluation of low-risk patients with
unstable angina who are evaluated on an outpatient basis. In
most cases, testing should be performed within 72 hours of
presentation. In low- or intermediate-risk patients with unsta-
ble angina who have been hospitalized for evaluation, exer-
cise or pharmacological stress testing should generally be
performed unless cardiac catheterization is indicated. In
low-risk patients, testing can be performed when patients
have been free of active ischemic or heart failure symptoms
for a minimum of 8 to 12 hours (23). Intermediate-risk
patients can be tested after 2 to 3 days, but selected patients
can be evaluated earlier as part of a carefully constructed
chest pain management protocol (see section on chest pain
centers below). In general, as with patients with stable angina,
the exercise treadmill test should be the standard mode of
stress testing in patients with a normal resting ECG who are
not taking digoxin.
A majority of patients with unstable angina have an
underlying ruptured plaque and significant CAD. Some have
a ruptured plaque without angiographically significant lesions
in any coronary segment. Still others have no evidence of a
ruptured plaque or atherosclerotic coronary lesions. Little
evidence exists with which to define the safety of early
exercise testing in unstable angina (24,25). One review of this
area found 3 studies covering 632 patients with stabilized
unstable angina who had a 0.5% death or myocardial infarc-
tion rate within 24 hours of their exercise test (25).
The limited evidence available supports the use of exercise
testing in acute coronary syndrome patients with appropriate
indications as soon as the patient has stabilized clinically.
Larsson and colleagues (26) compared a symptom-limited
predischarge (3 to 7 days) exercise test with a test performed
at 1 month in 189 patients with unstable angina or non–Q-
wave infarction. The prognostic value of the 2 tests was
similar, but the earlier test identified additional patients who
would experience events during the period before the
1-month exercise test. In this population, these earlier events
represented one half of all events occurring during the first
year.
The Research on Instability in Coronary Artery Disease
(RISC) study group (27) examined the use of predischarge
REVISED TABLE 17. Short-Term Risk of Death or Nonfatal Myocardial Infarction in Patients With Unstable Angina
High Risk Intermediate Risk Low Risk
Feature At least 1 of the following features
must be present:
No high-risk feature but must have 1 of the
following:
No high- or intermediate-risk feature but may
have any of the following features:
History Prior MI, peripheral or cerebrovascular disease,
or CABG or prior aspirin use
Character of
pain
Prolonged ongoing (greater than 20
minutes) rest pain
Prolonged (greater than 20 minutes) rest
angina, now resolved, with moderate or high
likelihood of CAD
New-onset or progressive CCSC III or IV angina
in the past 2 weeks with moderate or high
likelihood of CAD
Rest angina (less than 20 minutes) or relieved
with rest or sublingual NTG)
Clinical findings Pulmonary edema, most likely related
to ischemia
Age older than 70 years
New or worsening MR murmur
S3 or new/worsening rales
Hypotension, bradycardia, tachycardia
Age older than 75 years
ECG findings Angina at rest with transient ST
changes greater than 0.05 mV
T-wave inversions greater than 0.2 mV Normal or unchanged ECG during an episode
of chest discomfort
BBB, new or presumed new Pathological Q waves
Sustained ventricular tachycardia
Biochemical
cardiac markers
Elevated (eg, troponin T or I greater
than 0.1 mg/mL)
Slightly elevated (eg, troponin T greater than
0.01 but less than 0.1 mg/mL)
Normal
MI indicates myocardial infarction; CABG, coronary artery bypass graft; CAD, coronary artery disease; NTG, nitroglycerin; CCSC, Canadian Cardiovascular Society
Classification; MR, mitral regurgitation; ECG, electrocardiography; and BBB, bundle-branch block.
Estimation of the short-term risks of death and nonfatal cardiac ischemic events in unstable angina is a complex multivariable problem that cannot be fully specified
in a table such as this. Therefore, the table is meant to offer general guidance and illustration rather than rigid algorithms. Adapted from Agency for Health Care Policy
and Research Clinical Practice Guideline No. 10, Unstable Angina: Diagnosis and Management, May 1994.
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symptom-limited bicycle exercise testing in 740 men admit-
ted with unstable angina (51%) or non–Q-wave myocardial
infarction (49%). The major independent predictors of 1-year
infarction-free survival in multivariable regression analysis
were the number of leads with ischemic ST-segment depres-
sion and peak exercise workload achieved.
In 766 unstable angina patients enrolled in the FRISC
study between 1992 and 1994 who had both a troponin T
level and a predischarge exercise test, the combination of a
positive troponin T and exercise-induced ST depression
stratified patients into groups with a risk of death or MI
ranging from 1% to 20% (28). In 395 women enrolled in
FRISC I with stabilized unstable angina who underwent a
symptom-limited stress test at days 5 to 8, risk for cardiac
events in the next 6 months could be stratified from 1% to
19%. Important exercise variables included not only ischemic
parameters such as ST depression and chest pain but also
parameters that reflected cardiac workload.
Chest Pain Centers
Over the last decade, an increasing experience has been
gained with the use of exercise testing in emergency depart-
ment chest pain centers (see new Table 17a) (25). The goal of
a chest pain center is to provide rapid and efficient risk
stratification and management for chest pain patients believed
to possibly have acute coronary disease. A variety of physical
and administrative setups have been used for chest pain
centers in medical centers across the country; review of these
details is beyond the scope of these guidelines. In most of the
published series, exercise testing has been reserved for the
investigation of patients who are low risk on the basis of
history and physical examination, 12-lead ECG, and serum
markers. In the study by Gibler et al (29), 1010 patients were
evaluated by clinical examination, 9 hours of continuous ST
monitoring, serial 12-lead ECGs, serial measurement of
creatine kinase-MB, and resting echocardiograms. Patients
without high-risk markers on the basis of this evaluation
(78%) underwent a symptom-limited Bruce exercise ECG
test. There were no adverse events from the testing, and the
authors estimated a 5% prevalence of CAD in the tested
population. These results are generally representative of the
results in the approximately 2100 chest pain patients who
have undergone exercise testing as part of a chest pain center
protocol report (see new Table 17a) (25). The prevalence of
CAD is extremely low in such chest pain patients, and the risk
of adverse events with testing is correspondingly low.
Farkouh and colleagues from the Mayo Clinic examined
the use of exercise testing in 424 intermediate-risk unstable
angina patients (as defined by the ACC/AHA Committee to
Develop Guidelines for the Management of Patients With
Unstable Angina) as part of a randomized trial of admission
to a chest pain unit versus standard hospital admission (30).
There was no significant difference in event rates (death,
myocardial infarction, or congestive heart failure) between
TABLE 17A. Summary of Studies Using Exercise ECG Testing in Chest Pain Centers
Group (year) Reference
No. of
Subjects
Follow-Up
Period
Exercise
ECG
Adverse
Events*
% Disease
Prevalence
Clinical
Outcome
Tsakonis et al (1991) 31 28 6.1 mo Modified Bruce (SLM) 0 0 Exercise testing was safe
Kerns et al (1993) 32 32 6 mo Bruce (APMHR) 0 0 Exercise testing was safe
Reduced cost vs admission
Gibler et al (1995) 29 1010 30 d Bruce (SLM) 0 5 Sensitivity29%
Specificity99.4%
Positive predictive value44%†
Negative predictive value98.7%†
Gomez et al (1996) 33 50, plus None Cornell (SLM) 0 6 No difference in clinical outcome
50 controls Reduced cost vs admitted control
Zalenski et al (1998) 34 317 None; patients
admitted for
reference
diagnosis
Modified Bruce 0 9.5 Sensitivity90%
Specificity50%‡
Negative predictive value98%‡
Polanczyk et al (1998) 35 276§ 6 mo Modified Bruce 0 25 Sensitivity73%
Specificity 74%
Negative predictive value98%
Farkouh et al (1998) 30 424 6 mo Not specified 0 Intermediate-risk patients were studied
No difference in clinical outcomes¶
Reduced cost vs admitted control
SLM indicates symptom-limited maximum end point; APMHR, age-predicted maximum heart rate end point.
*Death or myocardial infarction.
†With respect to diagnosis if admitted, and 30-day follow-up on all patients.
‡With respect to reference diagnosis from admission of all patients.
§Included 70 patients (25%) with a history of coronary heart disease.
¶Comparison of those admitted to hospital vs chest pain center.
Reprinted with permission from Stein et al, Circulation. 2000;102:1463–1467 (25).
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the 212 patients in the hospital admission group and the 212
patients in the chest pain unit group. Of the total chest pain
unit group, 60 patients met the criteria for hospitalization
before stress testing, 55 had an indeterminate or high-risk test
result, and 97 had a negative stress test. There were no
complications directly attributable to the performance of a
stress test in these patients.
These results demonstrate that exercise testing is safe in
low-risk chest pain patients who present to the emergency
department. In addition, testing appears safe in carefully
selected intermediate-risk patients. Use of early exercise
testing in emergency department chest pain centers improves
the efficiency of management of these patients (and may
lower costs) without compromising safety. However, exercise
testing in this setting should only be done as part of a
carefully constructed management protocol and only after the
patients have been screened for high-risk features or other
indicators for hospital admission.
Modification V
These revised recommendations (see top of page) incorporate
additional details that were published in the ACC/AHA
Guidelines for Management of Patients With Acute Myocar-
dial Infarction. They are incorporated here to ensure consis-
tency between guidelines. In the original text, these recom-
mendations appeared under the major heading “Myocardial
Infarction” beginning on page 280 (second paragraph).
Modification VI
These new recommendations (see next page) incorporate an
additional recommendation regarding the use of exercise
testing in asymptomatic diabetic patients. These recommen-
Modification V
1997 Exercise Testing Guideline Recommendation 2002 Exercise Testing Guideline Recommendation
Class I Class I
1. Before discharge for prognostic assessment, activity prescription,
evaluation of medical therapy (submaximal at about 4 to 7 days).*
1. Before discharge for prognostic assessment, activity prescription,
evaluation of medical therapy (submaximal at about 4 to 6 days).*
2. Early after discharge for prognostic assessment, activity prescription,
evaluation of medical therapy, and cardiac rehabilitation if the predischarge
exercise test was not done (symptom limited; about 14 to 21 days).*
2. Early after discharge for prognostic assessment, activity prescription,
evaluation of medical therapy, and cardiac rehabilitation if the predischarge
exercise test was not done (symptom limited; about 14 to 21 days).*
3. Late after discharge for prognostic assessment, activity prescription,
evaluation of medical therapy, and cardiac rehabilitation if the early exercise
test was submaximal (symptom limited; about 3 to 6 weeks).*
3. Late after discharge for prognostic assessment, activity prescription,
evaluation of medical therapy, and cardiac rehabilitation if the early exercise
test was submaximal (symptom limited; about 3 to 6 weeks).*
Class IIa Class IIa
1. After discharge for activity counseling and/or exercise training as part of
cardiac rehabilitation in patients who have undergone coronary
revascularization.
1. After discharge for activity counseling and/or exercise training as part of
cardiac rehabilitation in patients who have undergone coronary
revascularization.
Class IIb Class IIb
1. Before discharge in patients who have undergone cardiac catheterization
to identify ischemia in the distribution of a coronary lesion of borderline
severity.
2. Patients with the following ECG abnormalities: 1. Patients with the following ECG abnormalities:
● Complete left bundle-branch block ● Complete left bundle-branch block
● Pre-excitation syndrome ● Pre-excitation syndrome
● Left ventricular hypertrophy ● Left ventricular hypertrophy
● Digoxin therapy ● Digoxin therapy
● Greater than 1 mm of resting ST-segment depression ● Greater than 1 mm of resting ST-segment depression
● Electronically paced ventricular rhythm ● Electronically paced ventricular rhythm
3. Periodic monitoring in patients who continue to participate in exercise
training or cardiac rehabilitation.
2. Periodic monitoring in patients who continue to participate in exercise
training or cardiac rehabilitation.
Class III Class III
1. Severe comorbidity likely to limit life expectancy and/or candidacy for
revascularization.
1. Severe comorbidity likely to limit life expectancy and/or candidacy for
revascularization.
2. At any time to evaluate patients with acute myocardial infarction who
have uncompensated congestive heart failure, cardiac arrhythmia, or
noncardiac conditions that severely limit their ability to exercise. (Level of
Evidence: C)
3. Before discharge to evaluate patients who have already been selected
for, or have undergone, cardiac catheterization. Although a stress test may be
useful before or after catheterization to evaluate or identify ischemia in the
distribution of a coronary lesion of borderline severity, stress imaging tests are
recommended. (Level of Evidence: C)
*Exceptions are noted under Classes IIb and III.
1537JACC Vol. 40, No. 8, 2002 Gibbons et al.
October 16, 2002:1531–40 ACC/AHA 2002 Guideline Update for Exercise Testing
dations originally appeared under the major heading “Spe-
cial Groups” and the subheading “Asymptomatic Persons,”
beginning on page 290 (first column).
Modification VII
This revised text clarifies the new recommendation on asymp-
tomatic diabetic persons. It replaces text that originally
appeared under the major headings of “Special Groups” and
the subheading “Asymptomatic Persons,” beginning on page
291 (second column).
On the basis of prognostic considerations, asymptomatic
male patients older than 45 years with 1 or more risk factors
(hypercholesterolemia, hypertension, smoking, diabetes, or
family history of premature CAD) may obtain useful prog-
nostic information from exercise testing. The greater the
number of risk factors (ie, pretest probability), the more likely
the patient will profit from screening. For these purposes, risk
factors should be strictly defined (36): hypercholesterolemia
as total cholesterol greater than 240 mg per dL, hypertension
as systolic blood pressure greater than 140 mm Hg or dia-
stolic blood pressure greater than 90 mm Hg, smoking,
diabetes, and history of heart attack or sudden cardiac death
in a first-degree relative less than 60 years old. The impor-
tance of more intensive risk factor management in diabetic
persons has been increasingly recognized, as reflected in the
most recent national guidelines for cholesterol management
(ATP III), hypertension (JNC VI), and diabetes control (see
http://www.diabetes.org/main/info/link.jsp). In asymptomatic
Modification VIII
1997 Exercise Testing Guideline Recommendation 2002 Exercise Testing Guideline Recommendation
Class I Class I
1. In chronic aortic regurgitation, assessment of functional capacity and symptomatic responses
in patients with a history of equivocal symptoms.
Class IIa Class IIa
1. In chronic aortic regurgitation, evaluation of symptoms and functional capacity before
participation in athletic activities.
2. In chronic aortic regurgitation, prognostic assessment before aortic valve replacement in
asymptomatic or minimally symptomatic patients with left ventricular dysfunction.
Class IIb Class IIb
1. Evaluation of exercise capacity of patients with
valvular heart disease.*
1. Evaluation of exercise capacity in patients with valvular heart disease. Comprehensive
discussion is found in the ACC/AHA valvular heart disease guidelines.
Class III Class III
1. Diagnosis of CAD in patients with valvular heart
disease.
1. Diagnosis of CAD in patients with moderate to severe valvular disease or with the following
baseline ECG abnormalities:
● Pre-excitation
● Electronically paced ventricular rhythm
● Greater than 1 mm of ST depression
● Complete left bundle-branch block
*As noted earlier, the presence of symptomatic, severe aortic stenosis is a contraindication to exercise testing.
Modification VI
1997 Exercise Testing Guideline Recommendation 2002 Exercise Testing Guideline Recommendation
Class IIa Class IIa
1. Evaluation of asymptomatic persons with diabetes mellitus who plan to
start vigorous exercise. (Level of Evidence: C)
Class IIb Class IIb
1. Evaluation of persons with multiple risk factors.* 1. Evaluation of persons with multiple risk factors as a guide to
risk-reduction therapy.*
2. Evaluation of asymptomatic men older than 40 years and women older
than 50 years:
● Who plan to start vigorous exercise (especially if sedentary) or
● Who are involved in occupations in which impairment might impact
public safety or
● Who are at high risk for CAD due to other diseases (eg, chronic renal
failure)
2. Evaluation of asymptomatic men older than 45 years and women older
than 55 years:
● Who plan to start vigorous exercise (especially if sedentary) or
● Who are involved in occupations in which impairment might impact
public safety or
● Who are at high risk for CAD due to other diseases (eg, peripheral
vascular disease and chronic renal failure)
Class III Class III
1. Routine screening of asymptomatic men or women. 1. Routine screening of asymptomatic men or women.
*Multiple risk factors are defined36 as hypercholesterolemia (greater than 240 mg/dL), hypertension (systolic blood pressure greater than 140 mm Hg or diastolic
blood pressure greater than 90 mm Hg), smoking, diabetes, and family history of heart attack or sudden cardiac death in a first-degree relative younger than 60 years. An
alternative approach might be to select patients with a Framingham risk score consistent with at least a moderate risk of serious cardiac events within 5 years (38).
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diabetic persons, the likelihood of cardiovascular disease is
increased if at least 1 of the following is present: age older
than 35 years, type 2 diabetes greater than 10 years’ duration,
type 1 diabetes greater than 15 years’ duration, any additional
atherosclerotic risk factor for CAD, presence of microvascu-
lar disease (proliferative retinopathy or nephropathy, includ-
ing microalbuminuria), peripheral vascular disease, or auto-
nomic neuropathy. Exercise testing is recommended if an
individual meeting the criteria is about to embark on
moderate- to high-intensity exercise (37). An alternative
approach would be to study patients with a certain level of
cardiovascular risk expressed as a continuous variable and
therefore accounting for not only the presence but also the
severity of risk factors. Such data have been derived in
asymptomatic persons from the Framingham study (38).
Attempts to extend screening to persons with lower degrees
of risk are not recommended because screening is unlikely to
improve patient outcome.
Modification VIII
These revised recommendations (see bottom of previous
page) include many more detailed recommendations that
appeared in the ACC/AHA guidelines for management of
patients with valvular heart disease. They are incorporated
here to ensure consistency across the guidelines. These
recommendations originally appeared under the major head-
ing “Special Groups” and the subheading “Valvular Heart
Disease,” beginning on page 293 (second column). Addi-
tional text on this subject appears in the revised full-text
guidelines on the Internet.
Modification IX
These revised recommendations (see top of page) for the use
of exercise testing in the investigation of heart rhythm
disorders incorporate additional recommendations that ap-
peared in an earlier Bethesda conference on the subject of
screening competitive athletes. They are incorporated here to
ensure consistency among ACC statements. These recommen-
dations originally appeared under the major heading “Spe-
cial Groups” and the subheading “Investigation of Heart
Rhythm Disorders,” beginning on page 296 (first column).
Modification X
This new text describes the additional special group of
patients with hypertension. It represents a new subheading,
“Special Groups,” under the original heading “Evaluation of
Hypertension,” beginning on page 297 (first column).
Evaluation of Hypertension
Exercise testing has been used to identify patients with
abnormal blood pressure response destined to develop hyper-
tension. Identification of such patients may allow preventive
measures that would delay or prevent the onset of this
disease. In asymptomatic normotensive subjects, an exagger-
ated exercise systolic and diastolic blood pressure response
during exercise, exaggerated peak systolic blood pressure
greater than 214 mm Hg, or elevated systolic or diastolic
blood pressure at 3 minutes into recovery is associated with
significant increased long-term risk of hypertension (39,40).
Exercise tolerance is decreased in patients with poor blood
pressure control (41), and severe systemic hypertension may
cause exercise-induced ST depression in the absence of
atherosclerosis (42).
Replacement and New References
(References from the 1997 guidelines appear in normal type;
new references appear in boldface type.)
Modification IX
1997 Exercise Testing Guideline Recommendation 2002 Exercise Testing Guideline Recommendation
Class I Class I
1. Identification of appropriate settings in patients with rate-adaptive
pacemakers.
1. Identification of appropriate settings in patients with rate-adaptive
pacemakers.
2. Evaluation of congenital complete heart block in patients considering
increased physical activity or participation in competitive sports. (Level of
Evidence: C)
Class IIa Class IIa
1. Evaluation of patients with known or suspected exercise-induced
arrhythmias.
1. Evaluation of patients with known or suspected exercise-induced
arrhythmias.
2. Evaluation of medical, surgical, or ablative therapy in patients with
exercise-induced arrhythmias (including atrial fibrillation).
2. Evaluation of medical, surgical, or ablative therapy in patients with
exercise-induced arrhythmias (including atrial fibrillation).
Class IIb Class IIb
1. Investigation of isolated ventricular ectopic beats in middle-aged patients
without other evidence of CAD.
1. Investigation of isolated ventricular ectopic beats in middle-aged patients
without other evidence of CAD.
2. Investigation of prolonged first-degree atrioventricular block or type I
second degree Wenckebach, left bundle-branch block, right bundle-branch
block, or isolated ectopic beats in young patients considering participation in
competitive sports. (Level of Evidence: C)
Class III Class III
1. Investigation of isolated ectopic beats in young patients. 1. Routine investigation of isolated ectopic beats in young patients.
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